(Press-News.org) Among patients with Clostridium difficile infection (CDI) who recovered following standard treatment with the antibiotics metronidazole or vancomycin, oral administration of spores of a strain of C difficile that does not produce toxins colonized the gastrointestinal tract and significantly reduced CDI recurrence, according to a study in the May 5 issue of JAMA.
C difficile is the cause of one of the most common and deadly health care-associated infections, linked to 29,000 U.S. deaths each year. Rates of CDI remain at unprecedented high levels in U.S. hospitals. Clinical infection also has a recurrence rate of 25 percent to 30 percent among affected patients. Not all strains of C difficile produce toxins. Nontoxigenic C difficile strains that lack the genes for toxin production are also found in the hospital environment and can colonize hospitalized patients, although patients are usually asymptomatic. Gastrointestinal colonization by these nontoxigenic C difficile strains (in both humans and hamsters) has shown promising results as a potential way to prevent CDI, according to background information in the article.
Dale N. Gerding, M.D., of the Edward Hines Jr. VA Hospital, Hines, Il., and Loyola University Chicago, Maywood, Il., and colleagues randomly assigned 173 adult patients who were diagnosed as having CDI (first episode or first recurrence) to receive 1 of 4 treatments: oral liquid formulation of nontoxigenic C difficile strain M3 (VP20621; NTCD-M3), 104 spores/d for 7 days (n = 43), 107 spores/d for 7 days (n = 44), 107 spores/d for 14 days (n = 42), or placebo for 14 days (n = 44). Prior to enrollment, these patients had all successfully completed treatment with metronidazole, oral vancomycin, or both at 44 study centers in the United States, Canada, and Europe.
Among 168 patients who started treatment, 157 completed treatment. Clostridium difficile infection recurrence was 30 percent among patients receiving placebo compared with 11 percent among all patients receiving NTCD-M3. The lowest recurrence was in 5 percent of patients receiving 107 spores/d for 7 days. Fecal colonization with NTCD-M3 occurred in 69 percent of NTCD-M3 patients: 71 percent with 107 spores/d and 63 percent with 104 spores/d. Colonization with NTCD correlated with reduced recurrence of CDI: recurrence occurred in 2 percent patients who were colonized vs 31 percent of patients who received NTCD-M3 but were not colonized.
One or more treatment-emergent adverse events were reported in 78 percent of patients receiving NTCD-M3 and 86 percent of patients receiving placebo. Diarrhea and abdominal pain were reported in 46 percent and 17 percent of patients receiving NTCD-M3 and 60 percent and 33 percent of placebo patients, respectively. Serious treatment-emergent adverse events were reported in 7 percent of patients receiving placebo and 3 percent of all patients who received NTCD-M3. Headache was reported in 10 percent of patients receiving NTCD-M3 and 2 percent of placebo patients.
The researchers write that the mechanism by which NTCD prevents recurrent CDI is not known; however, there may be an association with the presence of NTCD in the stool (colonization) with reduced infection from toxigenic C difficile and in animal models with prevention of CDI when challenged with toxigenic strains. "The most likely hypothesized mechanism of action of NTCD-M3 is that it occupies the same metabolic or adherence niche in the gastrointestinal tract as does toxigenic C difficile and, once established, is able to outcompete resident or newly ingested toxigenic strains."
The authors note that the sample size of the study was small, so many of the findings should be confirmed in larger studies.
INFORMATION:
(doi:10.1001/jama.2015.3725; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: This study was sponsored by ViroPharma Incorporated, which is now part of the Shire group of companies. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, etc.
In what is a major step towards the prevention of recurring bouts of Clostridium difficile (Cdiff) infection, an international team led by Dale Gerding, MD, Hines Veterans Administration (VA) research physician and professor of Medicine at Loyola University Chicago Stritch School of Medicine, has shown that giving spores of non-toxic Cdiff by mouth is effective in stopping repeated bouts of Cdiff infection which occurs in 25-30 percent of patients who suffer an initial episode of diarrhea or colitis. The study is published in the May 5 issue of the Journal of American ...
For the first time, scientists have imaged thunder, visually capturing the sound waves created by artificially triggered lightning. Researchers from Southwest Research Institute (SwRI) are presenting the first images at a joint meeting of American and Canadian geophysical societies in Montreal, Canada, May 3-7.
"Lightning strikes the Earth more than 4 million times a day, yet the physics behind this violent process remain poorly understood," said Dr. Maher A. Dayeh, a research scientist in the SwRI Space Science and Engineering Division. "While we understand the general ...
Employing online training programs to teach psychotherapists how to use newer evidence-based treatments can be as successful as in-person instruction, according to a new RAND Corporation study.
Psychotherapy treatments can lag years behind what research has shown to be effective because there simply are not enough clinicians trained in new methods. That means that many people with mental health disorders are not getting the most effective nonpharmacological treatments, RAND researchers say.
For one such treatment, Interpersonal and Social Rhythm Therapy to treat bipolar ...
Tropical Storm Noul is still threatening Yap Island located in the Caroline Islands of the western Pacific Ocean, and a part of the Federated States of Micronesia. Micronesia has posted a typhoon warning for the tiny island. The storm is currently 22 miles south-southwest of Ulithi (one of the outer islands of the State of Yap) and is moving west at 2 knots per hour. Maximum sustained winds for the storm is 55 knots gusting to 70 knots and maximum wave height is 20 feet.
Noul is moving to the west and is expected to veer west northwest and later to the northwest. ...
After gobbling the fourth Oreo in a row while bathed in refrigerator light, have you ever thought, "That wasn't enough," and then proceeded to search for something more?
Researchers at BYU have shed new light on why you, your friends, neighbors and most everyone you know tend to snack at night: some areas of the brain don't get the same "food high" in the evening.
In a newly published study, exercise sciences professors and a neuroscientist at BYU used MRI to measure how people's brains respond to high- and low-calorie food images at different times of the day. The ...
Anxiety disorders affect approximately one in six adult Americans, according to the National Institute of Mental Health. The most well-known of these include panic disorder, post-traumatic stress disorder, obsessive-compulsive disorder, and social anxiety disorder. But what of brief bouts of anxiety caused by stressful social situations?
A new study by Tel Aviv University researchers, published recently in the Journal of Oral Rehabilitation, finds that anxiety experienced in social circumstances elevates the risk of bruxism - teeth grinding which causes tooth wear and ...
BUFFALO, N.Y. -- Cells that relay information from the ear to the brain can change in significant ways in response to the noise level in the environment.
That's one major finding of a study out today in the Early Edition of the Proceedings of the National Academy of Sciences.
Expose the cells to loud sounds for a prolonged period of time, and they alter their behavior and even their structure in a manner that may aid hearing in the midst of noise. End the ruckus, and the cells change again to accommodate for quieter environs.
"The brain is amazingly adaptable: The ...
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
"These medications have to be dosed in a careful way," says senior investigator Adam Kaplin, M.D., Ph.D., an assistant professor of psychiatry and neurology at the Johns Hopkins University School of Medicine. ...
(Winston-Salem, N.C. - May 5, 2015) - Researchers from Wake Forest University and the University of Utah are the first to successfully fabricate halide organic-inorganic hybrid perovskite field-effect transistors and measure their electrical characteristics at room temperature.
"We designed the structure of these field-effect transistors that allowed us to achieve electrostatic gating of these materials and determine directly their electrical properties," said lead author, Oana Jurchescu, an assistant professor of physics at Wake Forest. "Then we fabricated these transistors ...
HOUSTON -- ( May 5, 2015 ) -- The effectiveness of cancer vaccines could be dramatically boosted by first loading the cancer antigens into silicon microparticles, report scientists from Houston Methodist and two other institutions in an upcoming Cell Reports (early online).
Model studies showed that microparticles loaded with an antigen, HER2, not only protected the antigen from premature destruction, but also stimulated the immune system to recognize and relentlessly attack cancer cells overexpressing the HER2 antigen.
"We could completely inhibit tumor growth after ...
